Free Trial

SA Regulator Approves Ivermectin Use Against Covid-19

SOUTH AFRICA
  • S. AFRICA HEALTH REGULATOR TO ALLOW `COMPASSIONATE' USE OF IVERMECTIN
  • Ivermectin is a vetinary product, that has show an ability to fight Covid-19 and was safe, fast acting, inexpensive and effective in trials
  • -Studies indicate that it assists the body's immune system to "fight back" and recover, often within a short period of only 48 hours
MNI London Bureau | +44 020-3983-7894 | murray.nichol@marketnews.com
MNI London Bureau | +44 020-3983-7894 | murray.nichol@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.